{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:44:55Z","timestamp":1767141895810,"version":"build-2238731810"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100019412","name":"Bursa Uluda\u011f \u00dcniversitesi","doi-asserted-by":"publisher","award":["DDP(F)-2020\/5."],"award-info":[{"award-number":["DDP(F)-2020\/5."]}],"id":[{"id":"10.13039\/100019412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09958-9","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T01:25:08Z","timestamp":1727745908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-796X","authenticated-orcid":false,"given":"Elif","family":"Erturk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6729-7908","authenticated-orcid":false,"given":"Ferda","family":"Ari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2805-8154","authenticated-orcid":false,"given":"Omer Enes","family":"Onur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-2630","authenticated-orcid":false,"given":"Sehsuvar","family":"Mustafa Gokgoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-0515","authenticated-orcid":false,"given":"Sahsine","family":"Tolunay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"9958_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mito.2022.08.002","volume":"66","author":"E Erturk","year":"2022","unstructured":"Erturk E, Enes Onur O, Akgun O, Tuna G, Yildiz Y, Ari F (2022) Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers. Mitochondrion 66:74\u201381. https:\/\/doi.org\/10.1016\/j.mito.2022.08.002","journal-title":"Mitochondrion"},{"issue":"4","key":"9958_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152032","volume":"11","author":"M Al-Khanbashi","year":"2016","unstructured":"Al-Khanbashi M, Caramuta S, Alajmi AM, Al-Haddabi I, Al-Riyami M, Lui WO, Al-Moundhri MS (2016) Tissue and serum miRNA profile in locally advanced breast cancer (LABC) in response to neo-adjuvant chemotherapy (NAC) treatment. PLoS ONE 11(4):e0152032. https:\/\/doi.org\/10.1371\/journal.pone.0152032","journal-title":"PLoS ONE"},{"issue":"2","key":"9958_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12282-017-0814-8","volume":"25","author":"M Adhami","year":"2018","unstructured":"Adhami M, Haghdoost AA, Sadeghi B, Malekpour Afshar R (2018) Candidate miRNAs in human breast cancer biomarkers: a systematic review. Breast Cancer (Tokyo, Japan) 25(2):198\u2013205. https:\/\/doi.org\/10.1007\/s12282-017-0814-8","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"5","key":"9958_CR4","doi-asserted-by":"publisher","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279","volume":"7","author":"FM Blows","year":"2010","unstructured":"Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkil\u00e4 P, Heikkinen T, Nevanlinna H, Akslen LA, B\u00e9gin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Huntsman D (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7(5):e1000279. https:\/\/doi.org\/10.1371\/journal.pmed.1000279","journal-title":"PLoS Med"},{"issue":"10","key":"9958_CR5","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, Shi B (2015) Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res 5(10):2929\u20132943","journal-title":"Am J Cancer Res"},{"issue":"12","key":"9958_CR6","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","volume":"44","author":"Z Yu","year":"2012","unstructured":"Yu Z, Pestell TG, Lisanti MP, Pestell RG (2012) Cancer stem cells. Int J Biochem Cell Biol 44(12):2144\u20132151. https:\/\/doi.org\/10.1016\/j.biocel.2012.08.022","journal-title":"Int J Biochem Cell Biol"},{"issue":"24","key":"9958_CR7","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.1158\/1078-0432.CCR-12-1436","volume":"18","author":"N Duru","year":"2012","unstructured":"Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ (2012) HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clin Cancer Res Off J Am Assoc Cancer Res 18(24):6634\u20136647. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1436","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"4","key":"9958_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara JA, Monge C, Yang Y, Takebe N (2020) Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol 17(4):204\u2013232. https:\/\/doi.org\/10.1038\/s41571-019-0293-2","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"9958_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"LA Macfarlane","year":"2010","unstructured":"Macfarlane LA, Murphy PR (2010) MicroRNA: biogenesis, function and role in cancer. Curr Gen 11(7):537\u2013561. https:\/\/doi.org\/10.2174\/138920210793175895","journal-title":"Curr Gen"},{"issue":"20","key":"9958_CR10","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/onc.2013.226","volume":"33","author":"Q Li","year":"2014","unstructured":"Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q (2014) Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene 33(20):2589\u20132600. https:\/\/doi.org\/10.1038\/onc.2013.226","journal-title":"Oncogene"},{"key":"9958_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S (2021) MicroRNA: a signature for cancer progression. Biomed Pharmacother 138:111528. https:\/\/doi.org\/10.1016\/j.biopha.2021.111528","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"9958_CR12","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3390\/diagnostics13193072","volume":"13","author":"JP Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz JP, P\u00e9rez-Moreno P, P\u00e9rez Y, Calaf GM (2023) The Role of MicroRNAs in breast cancer and the challenges of their clinical application. Diagnostics (Basel). 13(19):3072. https:\/\/doi.org\/10.3390\/diagnostics13193072","journal-title":"Diagnostics (Basel)."},{"issue":"12","key":"9958_CR13","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.1007\/s11033-023-08850-2","volume":"50","author":"Y Sahin","year":"2023","unstructured":"Sahin Y, Altan Z, Karabulut A, Saadat KASM, Arslan A (2023) The role of miR-223 in breast cancer; an integrated analysis. Mol Biol Rep 50(12):10179\u201310188. https:\/\/doi.org\/10.1007\/s11033-023-08850-2","journal-title":"Mol Biol Rep"},{"key":"9958_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155277","volume":"256","author":"S Ghafouri-Fard","year":"2024","unstructured":"Ghafouri-Fard S, Hussen BM, Eslami S (2024) Identification of miR-125a and miR-106b signature as a potential diagnostic biomarker in breast cancer tissues. Pathol Res Pract 256:155277. https:\/\/doi.org\/10.1016\/j.prp.2024.155277","journal-title":"Pathol Res Pract"},{"issue":"1","key":"9958_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41467-017-01059-5","volume":"8","author":"C Lv","year":"2017","unstructured":"Lv C, Li F, Li X, Tian Y, Zhang Y, Sheng X, Song Y, Meng Q, Yuan S, Luan L, Andl T, Feng X, Jiao B, Xu M, Plikus MV, Dai X, Lengner C, Cui W, Ren F, Shuai J, Yu Z (2017) MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists. Nat Commun 8(1):1036. https:\/\/doi.org\/10.1038\/s41467-017-01059-5","journal-title":"Nat Commun"},{"key":"9958_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/gcc.22107","volume":"52","author":"EM Laurila","year":"2013","unstructured":"Laurila EM, Kallioniemi A (2013) The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosomes Cancer 52:1103\u20131113. https:\/\/doi.org\/10.1002\/gcc.22107","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"9958_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3892\/ol.2012.841","volume":"4","author":"Z Lu","year":"2012","unstructured":"Lu Z, Ye Y, Jiao D, Qiao J, Cui S, Liu Z (2012) miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status. Oncol Lett 4(5):1027\u20131032. https:\/\/doi.org\/10.3892\/ol.2012.841","journal-title":"Oncol Lett"},{"issue":"1","key":"9958_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2217\/fon.09.150","volume":"6","author":"TD Schmittgen","year":"2010","unstructured":"Schmittgen TD (2010) miR-31: a master regulator of metastasis? Future oncology (London, England) 6(1):17\u201320. https:\/\/doi.org\/10.2217\/fon.09.150","journal-title":"Future oncology (London, England)"},{"key":"9958_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-4598-11-5","volume":"11","author":"K Augoff","year":"2012","unstructured":"Augoff K, McCue B, Plow EF, Sossey-Alaoui K (2012) miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 11:5. https:\/\/doi.org\/10.1186\/1476-4598-11-5","journal-title":"Mol Cancer"},{"key":"9958_CR20","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2147\/OTT.S189265","volume":"12","author":"W Shi","year":"2019","unstructured":"Shi W, Dong F, Jiang Y, Lu L, Wang C, Tan J, Yang W, Guo H, Ming J, Huang T (2019) Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis. Onco Targets Ther 12:1979\u20132010. https:\/\/doi.org\/10.2147\/OTT.S189265","journal-title":"Onco Targets Ther"},{"issue":"1","key":"9958_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s13104-019-4653-x","volume":"12","author":"AA Hashmi","year":"2019","unstructured":"Hashmi AA, Hashmi KA, Irfan M, Khan SM, Edhi MM, Ali JP, Hashmi SK, Asif H, Faridi N, Khan A (2019) Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters. BMC Res Notes 12(1):605. https:\/\/doi.org\/10.1186\/s13104-019-4653-x","journal-title":"BMC Res Notes"},{"issue":"5","key":"9958_CR22","first-page":"1290","volume":"23","author":"S Soheilyfar","year":"2018","unstructured":"Soheilyfar S, Velashjerdi Z, Sayed Hajizadeh Y et al (2018) In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer. J BUON 23(5):1290\u20131296","journal-title":"J BUON"},{"key":"9958_CR23","doi-asserted-by":"publisher","first-page":"828160","DOI":"10.3389\/fonc.2022.828160","volume":"12","author":"X Tian","year":"2022","unstructured":"Tian X, Lu J, Nanding K et al (2022) The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31. Front Oncol 12:828160. https:\/\/doi.org\/10.3389\/fonc.2022.828160","journal-title":"Front Oncol"},{"key":"9958_CR24","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180019","author":"Z Tan","year":"2018","unstructured":"Tan Z, Jia J, Jiang Y (2018) MiR-150-3p targets SP1 and suppresses the growth of glioma cells. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20180019"},{"issue":"4","key":"9958_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.anl.2017.11.019","volume":"45","author":"K Koshizuka","year":"2018","unstructured":"Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N (2018) Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Auris Nasus Larynx 45(4):854\u2013865. https:\/\/doi.org\/10.1016\/j.anl.2017.11.019","journal-title":"Auris Nasus Larynx"},{"issue":"12","key":"9958_CR26","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/biomedicines9121883","volume":"9","author":"K Mizuno","year":"2021","unstructured":"Mizuno K, Tanigawa K, Misono S, Suetsugu T, Sanada H, Uchida A, Kawano M, Machida K, Asai S, Moriya S, Inoue H, Seki N (2021) Regulation of oncogenic targets by tumor-suppressive miR-150-3p in lung squamous cell carcinoma. Biomedicines 9(12):1883. https:\/\/doi.org\/10.3390\/biomedicines9121883","journal-title":"Biomedicines"},{"issue":"11","key":"9958_CR27","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1097\/01.pas.0000138183.97366.fd","volume":"28","author":"MM Koker","year":"2004","unstructured":"Koker MM, Kleer CG (2004) p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 28(11):1506\u20131512. https:\/\/doi.org\/10.1097\/01.pas.0000138183.97366.fd","journal-title":"Am J Surg Pathol"}],"updated-by":[{"DOI":"10.1007\/s11033-024-10010-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09958-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:26:16Z","timestamp":1738711576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09958-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9958"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09958-9","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-024-10010-z","URL":"https:\/\/doi.org\/10.1007\/s11033-024-10010-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bursa Uludag University Clinical Research Ethics Committee (2019-21\/20).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the tables and figures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"1030"}}